No Undisclosed or Contingent Liabilities. Neither the Company nor any of its Subsidiaries has any claims, liabilities or obligations of any nature whatsoever (whether absolute, accrued, contingent or otherwise and whether due or to become due) that would be required to be reflected or reserved against on a consolidated balance sheet of the Company and its consolidated Subsidiaries under GAAP, except for claims, liabilities or obligations (i) reflected or reserved against on the Balance Sheet, (ii) disclosed in the Company's most recent Form 10-K or any SEC Document filed subsequent to such Form 10-K and prior to the date hereof or (iii) incurred by the Company or any of its Subsidiaries since June 30, 1996 in the ordinary course of business and consistent with past practice and that, individually or in the aggregate, would not have a Material Adverse Effect.
Appears in 1 contract
Samples: Stock Subscription Agreement (Icn Pharmaceuticals Inc)
No Undisclosed or Contingent Liabilities. Neither the Company nor any of its Subsidiaries has any claims, liabilities or obligations of any nature whatsoever (whether absolute, accrued, contingent or otherwise and whether due or to become due) that would be required to be reflected or reserved against on a consolidated balance sheet of the Company and its consolidated Subsidiaries under GAAP, except for claims, liabilities or obligations (i) reflected or reserved against on the Balance Sheet, (ii) disclosed in the Company's most recent Form 10-K or any SEC Document filed subsequent to such Form 10-K and prior to the date hereof or (iii) incurred by the Company or any of its Subsidiaries since June September 30, 1996 2000 in the ordinary course of business and consistent with past practice and that, individually or in the aggregate, would not have a Material Adverse EffectEffect or (iv) as set forth in the Disclosure Schedule.
Appears in 1 contract
Samples: Structured Equity Line Flexible Financing Agreement (Cygnus Inc /De/)
No Undisclosed or Contingent Liabilities. Neither the Company nor any of its Subsidiaries has any claims, liabilities or obligations of any nature whatsoever (whether absolute, accrued, contingent or otherwise and whether due or to become due) that would be required to be reflected or reserved against on a consolidated balance sheet of the Company and its consolidated Subsidiaries under GAAP, except for claims, liabilities or obligations (i) reflected or reserved against on the Balance Sheet, (ii) disclosed in the Company's most recent Form 10-K or any SEC Document filed subsequent to such Form 10-K and prior to the date hereof or (iii) incurred by the Company or any of its Subsidiaries since June 30March 31, 1996 1999 in the ordinary course of business and consistent with past practice and that, individually or in the aggregate, would not have a Material Adverse EffectEffect or (iv) as set forth in the Disclosure Schedule.
Appears in 1 contract
Samples: Structured Equity Line Flexible Financing Agreement (Cygnus Inc /De/)
No Undisclosed or Contingent Liabilities. Neither the Company nor any of its Subsidiaries has any claims, liabilities or obligations of any nature whatsoever (whether absolute, accrued, contingent or otherwise and whether due or to become due) that would be required to be reflected or reserved against on a consolidated balance sheet of the Company and its consolidated Subsidiaries under GAAP, except for claims, liabilities or obligations (i) reflected or reserved against on the Balance Sheet, (ii) disclosed in the Company's most recent Form 10-K or any SEC Document filed subsequent to such Form 10-K and prior to the date hereof or (iii) incurred by the Company or any of its Subsidiaries since June 30December 31, 1996 2000 in the ordinary course of business and consistent with past practice and that, individually or in the aggregate, would not have a Material Adverse EffectEffect or (iv) as set forth in the Disclosure Schedule.
Appears in 1 contract
Samples: Structured Equity Line Flexible Financing Agreement (Cygnus Inc /De/)